Skip to main content

Diabetes Drug News

Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.

Metformin     Insulin     SGLT-2     GLP-1     DPP-4     Combo drugs     Sulfonylureas     TZDs

Discover the latest in gestational diabetes management, including CGM technology, screening debates, and possible new treatments like inhaled insulin.
The daily pill Rezdiffra is the first treatment for people with a type of liver disease known as MASH, which affects up to 20% of people with type 2 diabetes.
The FDA has approved Wegovy (semaglutide) for reduction of major adverse cardiovascular events (MACE) in people with obesity and overweight and without diabetes, based...
In new studies presented at ATTD, CGM used with GLP-1s led to greater A1C reductions than GLP-1s alone.
Novo Nordisk’s FLOW trial was stopped early after results showed that Ozempic (semaglutide) slows progression of kidney disease in people with type 2 diabetes and CKD.
Exploring metformin as a treatment for gestational diabetes: This article delves into the efficacy, safety, and patient satisfaction of metformin compared to insulin,...
A recent study supports the idea that metformin may have a role in dementia prevention. Studies are ongoing to provide a definitive answer.
Every February, the Spare a Rose campaign raises funds to provide insulin and other diabetes supplies to people with type 1 in under-resourced countries. Spread the word...
Discover the hidden risks of diabetic ketoacidosis (DKA) in insulin-treated diabetes. Learn about euglycemic DKA, triggered by SGLT-2 inhibitors.
GLP-1 drugs like Ozempic show promise in addiction treatment, with ongoing research and clinical trials redefining recovery approaches.
2024 brings insulin price cuts but analysis shows 775 med price hikes, including diabetes drugs. Future price negotiations and affordability resources highlighted
Explore strategies for managing post-meal blood sugar spikes in diabetes, including adjusting insulin doses, dietary changes, and physical activity. Learn the importance...
New study in Diabetes, Obesity and Metabolism reveals Brenzavvy, an affordable SGLT-2 inhibitor for type 2 diabetes, is heart-safe and effective. It lowers blood sugar...
The FDA is investigating reports of suicidal thoughts or actions in people taking diabetes and weight loss medications like Ozempic, Wegovy, and Mounjaro. Research is...
LillyDirect, a new telehealth platform and online pharmacy, aims to improve access to resources and medication for people living with diabetes, obesity, and migraines.
The FDA is investigating the sale of counterfeit Ozempic. Here’s how to check that your Ozempic is real.
Vertex pauses VX-880 trial after two deaths; fate of diabetes treatment uncertain as current participants continue therapy.
Discover diaTribe's best 2023 diabetes articles on new treatments, advances in technology, lifestyle tips, and groundbreaking insights for better diabetes management.
Explore the emerging effects of GLP-1 receptor agonists on glycemic control and weight management, including their potential impact on birth control pill absorption and...
Study shows AI chatbot enhances insulin dosing for type 2 diabetes, improving glycemic control and reducing distress, marking a new era in diabetes management.

Pages